|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Stock Screener |
Insider Trading Graph View |
Insider Watch |
Insider Trading - BeiGene Ltd. (BGNE)
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2018-08-02 Purchase |
2018-08-06 5:22 pm |
BeiGene Ltd. | BGNE | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director, 10% Owner |
5,814,100 | $108 | $627,922,800 | 10,749,251 (Direct Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2018-12-17 Exercise |
2018-12-19 6:34 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Peterson Amy C. CMO, Immuno-oncology |
9,859 | $29.1 | 951,833 (Direct) |
View |
| 2018-12-17 Sale |
2018-12-19 6:34 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Peterson Amy C. CMO, Immuno-oncology |
900 | $130.4 | 951,833 (Direct) |
View |
| 2018-12-17 Sale |
2018-12-19 6:34 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Peterson Amy C. CMO, Immuno-oncology |
2,700 | $131.8 | 951,833 (Direct) |
View |
| 2018-12-17 Sale |
2018-12-19 6:34 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Peterson Amy C. CMO, Immuno-oncology |
1,700 | $132.9 | 951,833 (Direct) |
View |
| 2018-12-17 Sale |
2018-12-19 6:34 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Peterson Amy C. CMO, Immuno-oncology |
1,005 | $133.8 | 951,833 (Direct) |
View |
| 2018-12-17 Sale |
2018-12-19 6:34 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Peterson Amy C. CMO, Immuno-oncology |
778 | $135 | 951,833 (Direct) |
View |
| 2018-12-17 Sale |
2018-12-19 6:34 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Peterson Amy C. CMO, Immuno-oncology |
2,296 | $136.2 | 951,833 (Direct) |
View |
| 2018-12-17 Sale |
2018-12-19 6:34 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Peterson Amy C. CMO, Immuno-oncology |
480 | $136.9 | 951,833 (Direct) |
View |
| 2018-12-17 Exercise |
2018-12-19 6:34 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Peterson Amy C. CMO, Immuno-oncology |
10,141 | $29.1 | 951,833 (Direct) |
View |
| 2018-12-17 Sale |
2018-12-19 6:34 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Peterson Amy C. CMO, Immuno-oncology |
1,631 | $131.7 | 951,833 (Direct) |
View |
| 2018-12-17 Sale |
2018-12-19 6:34 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Peterson Amy C. CMO, Immuno-oncology |
1,897 | $132.7 | 951,833 (Direct) |
View |
| 2018-12-17 Sale |
2018-12-19 6:34 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Peterson Amy C. CMO, Immuno-oncology |
2,402 | $133.9 | 951,833 (Direct) |
View |
| 2018-12-17 Sale |
2018-12-19 6:34 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Peterson Amy C. CMO, Immuno-oncology |
3,600 | $134.8 | 951,833 (Direct) |
View |
| 2018-12-17 Sale |
2018-12-19 6:34 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Peterson Amy C. CMO, Immuno-oncology |
611 | $135.5 | 951,833 (Direct) |
View |
| 2018-12-17 Exercise |
2018-12-19 6:34 pm |
N/A 2026-08-21 |
BeiGene Ltd. | BGNE | Peterson Amy C. CMO, Immuno-oncology |
128,167 | $2.24 | 951,833 (Direct) |
View |
| 2018-12-17 Exercise |
2018-12-19 6:34 pm |
N/A 2026-08-21 |
BeiGene Ltd. | BGNE | Peterson Amy C. CMO, Immuno-oncology |
131,833 | $2.24 | 951,833 (Direct) |
View |
| 2018-12-10 Sale |
2018-12-12 5:28 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
400 | $133.6 | 29,439,116 (Indirect) |
View |
| 2018-12-10 Sale |
2018-12-12 5:28 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
860 | $134.7 | 29,439,116 (Indirect) |
View |
| 2018-12-10 Sale |
2018-12-12 5:28 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
1,171 | $135.7 | 29,439,116 (Indirect) |
View |
| 2018-12-10 Sale |
2018-12-12 5:28 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
1,307 | $136.6 | 29,439,116 (Indirect) |
View |
| 2018-12-10 Sale |
2018-12-12 5:28 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
400 | $137.6 | 29,439,116 (Indirect) |
View |
| 2018-12-03 Sale |
2018-12-04 5:35 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Xiaodong Director |
2,671 | $151 | 7,708,608 (Direct) |
View |
| 2018-12-03 Sale |
2018-12-04 5:35 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Xiaodong Director |
800 | $152 | 7,708,608 (Direct) |
View |
| 2018-12-03 Sale |
2018-12-04 5:35 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Xiaodong Director |
529 | $152.9 | 7,708,608 (Direct) |
View |
| 2018-12-03 Sale |
2018-12-04 5:35 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Xiaodong Director |
400 | $154.2 | 7,708,608 (Direct) |
View |
| 2018-12-03 Sale |
2018-12-04 5:35 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Xiaodong Director |
300 | $155.5 | 7,708,608 (Direct) |
View |
| 2018-12-03 Sale |
2018-12-04 5:35 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Xiaodong Director |
100 | $156.8 | 7,708,608 (Direct) |
View |
| 2018-12-03 Sale |
2018-12-04 5:35 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Xiaodong Director |
100 | $159.5 | 7,708,608 (Direct) |
View |
| 2018-12-03 Sale |
2018-12-04 5:35 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Xiaodong Director |
100 | $163.8 | 7,708,608 (Direct) |
View |
| 2018-11-26 Sale |
2018-11-28 7:26 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
200 | $135 | 29,439,116 (Indirect) |
View |
| 2018-11-26 Sale |
2018-11-28 7:26 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
2,000 | $136.8 | 29,439,116 (Indirect) |
View |
| 2018-11-26 Sale |
2018-11-28 7:26 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
1,400 | $138 | 29,439,116 (Indirect) |
View |
| 2018-11-26 Sale |
2018-11-28 7:26 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
968 | $139 | 29,439,116 (Indirect) |
View |
| 2018-11-26 Sale |
2018-11-28 7:26 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
2,605 | $140 | 29,439,116 (Indirect) |
View |
| 2018-11-26 Sale |
2018-11-28 7:26 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
1,100 | $141 | 29,439,116 (Indirect) |
View |
| 2018-11-26 Sale |
2018-11-28 7:26 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
805 | $142 | 29,439,116 (Indirect) |
View |
| 2018-11-26 Sale |
2018-11-28 7:26 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
200 | $139.6 | 29,439,116 (Indirect) |
View |
| 2018-11-26 Sale |
2018-11-28 7:26 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
200 | $141.1 | 29,439,116 (Indirect) |
View |
| 2018-11-26 Sale |
2018-11-28 7:26 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
800 | $142.4 | 29,439,116 (Indirect) |
View |
| 2018-11-26 Sale |
2018-11-28 7:26 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
1,629 | $143.7 | 29,439,116 (Indirect) |
View |
| 2018-11-26 Sale |
2018-11-28 7:26 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
3,475 | $144.6 | 29,439,116 (Indirect) |
View |
| 2018-11-26 Sale |
2018-11-28 7:26 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
4,148 | $145.4 | 29,439,116 (Indirect) |
View |
| 2018-11-26 Sale |
2018-11-28 7:26 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
800 | $146.4 | 29,439,116 (Indirect) |
View |
| 2018-11-26 Sale |
2018-11-28 7:26 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
500 | $143.7 | 29,439,116 (Indirect) |
View |
| 2018-11-26 Sale |
2018-11-28 7:26 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
800 | $144.7 | 29,439,116 (Indirect) |
View |
| 2018-11-26 Sale |
2018-11-28 7:26 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
1,000 | $145.9 | 29,439,116 (Indirect) |
View |
| 2018-11-26 Sale |
2018-11-28 7:26 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
2,575 | $146.7 | 29,439,116 (Indirect) |
View |
| 2018-11-26 Sale |
2018-11-28 7:26 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
1,000 | $147.8 | 29,439,116 (Indirect) |
View |
| 2018-11-26 Sale |
2018-11-28 7:26 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
2,190 | $148.9 | 29,439,116 (Indirect) |
View |
| 2018-11-26 Sale |
2018-11-28 7:26 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
800 | $149.7 | 29,439,116 (Indirect) |
View |
| 2018-11-26 Exercise |
2018-11-28 7:25 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
3,000 | $29.49 | 1,328,500 (Direct) |
View |
| 2018-11-26 Sale |
2018-11-28 7:25 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
3,000 | $139.6 | 1,328,500 (Direct) |
View |
| 2018-11-26 Exercise |
2018-11-28 7:25 pm |
N/A 2026-09-02 |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
39,000 | $2.27 | 1,328,500 (Direct) |
View |
| 2018-11-27 Gift |
2018-11-28 7:23 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Xiaodong Director |
89,999 | $0 | 7,773,608 (Direct) |
View |
| 2018-11-19 Gift |
2018-11-21 6:42 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Glazer Donald W. Director |
3,138 | $0 | 4,133,802 (Direct) |
View |
| 2018-11-19 Gift |
2018-11-21 6:42 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Glazer Donald W. Director |
3,138 | $0 | 4,133,802 (Direct) |
View |
| 2018-11-19 Gift |
2018-11-21 6:42 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Glazer Donald W. Director |
3,138 | $0 | 4,133,802 (Direct) |
View |
| 2018-11-19 Sale |
2018-11-21 6:41 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Xiaodong Director |
1,100 | $122.5 | 7,863,607 (Direct) |
View |
| 2018-11-19 Sale |
2018-11-21 6:41 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Xiaodong Director |
1,277 | $123.7 | 7,863,607 (Direct) |
View |
| 2018-11-19 Sale |
2018-11-21 6:41 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Xiaodong Director |
1,173 | $124.6 | 7,863,607 (Direct) |
View |
| 2018-11-19 Sale |
2018-11-21 6:41 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Xiaodong Director |
850 | $125.6 | 7,863,607 (Direct) |
View |
| 2018-11-19 Sale |
2018-11-21 6:41 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Xiaodong Director |
600 | $126.5 | 7,863,607 (Direct) |
View |
| 2018-11-08 Exercise |
2018-11-13 10:20 am |
N/A N/A |
BeiGene Ltd. | BGNE | Peterson Amy C. CMO, Immuno-oncology |
14,711 | $29.1 | 1,408,757 (Direct) |
View |
| 2018-11-08 Sale |
2018-11-13 10:20 am |
N/A N/A |
BeiGene Ltd. | BGNE | Peterson Amy C. CMO, Immuno-oncology |
466 | $122.9 | 1,408,757 (Direct) |
View |
| 2018-11-08 Sale |
2018-11-13 10:20 am |
N/A N/A |
BeiGene Ltd. | BGNE | Peterson Amy C. CMO, Immuno-oncology |
2,423 | $124.5 | 1,408,757 (Direct) |
View |
| 2018-11-08 Sale |
2018-11-13 10:20 am |
N/A N/A |
BeiGene Ltd. | BGNE | Peterson Amy C. CMO, Immuno-oncology |
3,949 | $126.1 | 1,408,757 (Direct) |
View |
| 2018-11-08 Sale |
2018-11-13 10:20 am |
N/A N/A |
BeiGene Ltd. | BGNE | Peterson Amy C. CMO, Immuno-oncology |
7,673 | $126.7 | 1,408,757 (Direct) |
View |
| 2018-11-08 Sale |
2018-11-13 10:20 am |
N/A N/A |
BeiGene Ltd. | BGNE | Peterson Amy C. CMO, Immuno-oncology |
200 | $127.6 | 1,408,757 (Direct) |
View |
| 2018-11-08 Exercise |
2018-11-13 10:20 am |
N/A N/A |
BeiGene Ltd. | BGNE | Peterson Amy C. CMO, Immuno-oncology |
13,222 | $29.1 | 1,408,757 (Direct) |
View |
| 2018-11-08 Sale |
2018-11-13 10:20 am |
N/A N/A |
BeiGene Ltd. | BGNE | Peterson Amy C. CMO, Immuno-oncology |
4,031 | $118.6 | 1,408,757 (Direct) |
View |
| 2018-11-08 Sale |
2018-11-13 10:20 am |
N/A N/A |
BeiGene Ltd. | BGNE | Peterson Amy C. CMO, Immuno-oncology |
1,725 | $119.3 | 1,408,757 (Direct) |
View |
| 2018-11-08 Sale |
2018-11-13 10:20 am |
N/A N/A |
BeiGene Ltd. | BGNE | Peterson Amy C. CMO, Immuno-oncology |
2,100 | $120.6 | 1,408,757 (Direct) |
View |
| 2018-11-08 Sale |
2018-11-13 10:20 am |
N/A N/A |
BeiGene Ltd. | BGNE | Peterson Amy C. CMO, Immuno-oncology |
2,898 | $121.7 | 1,408,757 (Direct) |
View |
| 2018-11-08 Sale |
2018-11-13 10:20 am |
N/A N/A |
BeiGene Ltd. | BGNE | Peterson Amy C. CMO, Immuno-oncology |
2,046 | $122.5 | 1,408,757 (Direct) |
View |
| 2018-11-08 Sale |
2018-11-13 10:20 am |
N/A N/A |
BeiGene Ltd. | BGNE | Peterson Amy C. CMO, Immuno-oncology |
322 | $123.7 | 1,408,757 (Direct) |
View |
| 2018-11-08 Sale |
2018-11-13 10:20 am |
N/A N/A |
BeiGene Ltd. | BGNE | Peterson Amy C. CMO, Immuno-oncology |
100 | $126 | 1,408,757 (Direct) |
View |
| 2018-11-08 Exercise |
2018-11-13 10:20 am |
N/A N/A |
BeiGene Ltd. | BGNE | Peterson Amy C. CMO, Immuno-oncology |
12,067 | $29.1 | 1,408,757 (Direct) |
View |
| 2018-11-08 Sale |
2018-11-13 10:20 am |
N/A N/A |
BeiGene Ltd. | BGNE | Peterson Amy C. CMO, Immuno-oncology |
2,958 | $111.1 | 1,408,757 (Direct) |
View |
| 2018-11-08 Sale |
2018-11-13 10:20 am |
N/A N/A |
BeiGene Ltd. | BGNE | Peterson Amy C. CMO, Immuno-oncology |
4,000 | $112.2 | 1,408,757 (Direct) |
View |
| 2018-11-08 Sale |
2018-11-13 10:20 am |
N/A N/A |
BeiGene Ltd. | BGNE | Peterson Amy C. CMO, Immuno-oncology |
2,527 | $113 | 1,408,757 (Direct) |
View |
| 2018-11-08 Sale |
2018-11-13 10:20 am |
N/A N/A |
BeiGene Ltd. | BGNE | Peterson Amy C. CMO, Immuno-oncology |
1,173 | $113.9 | 1,408,757 (Direct) |
View |
| 2018-11-08 Sale |
2018-11-13 10:20 am |
N/A N/A |
BeiGene Ltd. | BGNE | Peterson Amy C. CMO, Immuno-oncology |
700 | $115 | 1,408,757 (Direct) |
View |
| 2018-11-08 Sale |
2018-11-13 10:20 am |
N/A N/A |
BeiGene Ltd. | BGNE | Peterson Amy C. CMO, Immuno-oncology |
500 | $116.6 | 1,408,757 (Direct) |
View |
| 2018-11-08 Sale |
2018-11-13 10:20 am |
N/A N/A |
BeiGene Ltd. | BGNE | Peterson Amy C. CMO, Immuno-oncology |
109 | $117.6 | 1,408,757 (Direct) |
View |
| 2018-11-08 Sale |
2018-11-13 10:20 am |
N/A N/A |
BeiGene Ltd. | BGNE | Peterson Amy C. CMO, Immuno-oncology |
100 | $121.6 | 1,408,757 (Direct) |
View |
| 2018-11-08 Exercise |
2018-11-13 10:20 am |
N/A 2026-08-21 |
BeiGene Ltd. | BGNE | Peterson Amy C. CMO, Immuno-oncology |
191,243 | $2.24 | 1,408,757 (Direct) |
View |
| 2018-11-08 Exercise |
2018-11-13 10:20 am |
N/A 2026-08-21 |
BeiGene Ltd. | BGNE | Peterson Amy C. CMO, Immuno-oncology |
171,886 | $2.24 | 1,408,757 (Direct) |
View |
| 2018-11-08 Exercise |
2018-11-13 10:20 am |
N/A 2026-08-21 |
BeiGene Ltd. | BGNE | Peterson Amy C. CMO, Immuno-oncology |
156,871 | $2.24 | 1,408,757 (Direct) |
View |
| 2018-09-04 Sale |
2018-09-05 5:15 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
2,911 | $174.6 | 271,621 (Direct) |
View |
| 2018-08-29 Sale |
2018-08-31 4:54 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Glazer Donald W. Director |
1,000 | $179 | 4,136,940 (Direct) |
View |
| 2018-08-29 Sale |
2018-08-31 4:54 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Glazer Donald W. Director |
1,000 | $179 | 4,136,940 (Direct) |
View |
| 2018-08-23 Sale |
2018-08-24 4:25 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Peterson Amy C. CMO, Immuno-oncology |
1,108 | $167.5 | 194,569 (Direct) |
View |
| 2018-08-23 Sale |
2018-08-24 4:25 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Peterson Amy C. CMO, Immuno-oncology |
2,300 | $168.9 | 194,569 (Direct) |
View |
| 2018-08-23 Sale |
2018-08-24 4:25 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Peterson Amy C. CMO, Immuno-oncology |
1,400 | $169.8 | 194,569 (Direct) |
View |
| 2018-08-23 Sale |
2018-08-24 4:25 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Peterson Amy C. CMO, Immuno-oncology |
961 | $170.5 | 194,569 (Direct) |
View |
| 2018-08-13 Sale |
2018-08-15 4:23 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Xiaodong Director |
2,200 | $157.3 | 7,928,607 (Direct) |
View |
| 2018-08-13 Sale |
2018-08-15 4:23 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Xiaodong Director |
700 | $159.2 | 7,928,607 (Direct) |
View |
| 2018-08-13 Sale |
2018-08-15 4:23 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Xiaodong Director |
549 | $164.1 | 7,928,607 (Direct) |
View |
| 2018-07-16 Sale |
2018-07-17 5:02 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO, 10% Owner |
2,550 | $164.1 | 29,872,444 (Direct) |
View |
| 2018-06-26 Option Award |
2018-06-28 7:44 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO, 10% Owner |
188,266 | $0 | 29,872,444 (Direct) |
View |
| 2018-06-26 Option Award |
2018-06-28 7:44 pm |
N/A 2028-06-25 |
BeiGene Ltd. | BGNE | OYLER JOHN CEO, 10% Owner |
1,310,088 | $12.34 | 29,872,444 (Direct) |
View |
| 2018-06-26 Option Award |
2018-06-28 7:43 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Liang Howard CFO |
52,338 | $0 | 364,208 (Direct) |
View |
| 2018-06-26 Option Award |
2018-06-28 7:43 pm |
N/A 2028-06-25 |
BeiGene Ltd. | BGNE | Liang Howard CFO |
364,208 | $12.34 | 364,208 (Direct) |
View |
| 2018-06-26 Option Award |
2018-06-28 7:42 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
44,564 | $0 | 310,180 (Direct) |
View |
| 2018-06-26 Option Award |
2018-06-28 7:42 pm |
N/A 2028-06-25 |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
310,180 | $12.34 | 310,180 (Direct) |
View |
| 2018-06-26 Option Award |
2018-06-28 7:41 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Peterson Amy C. CMO, Immuno-oncology |
44,564 | $0 | 310,180 (Direct) |
View |
| 2018-06-26 Option Award |
2018-06-28 7:41 pm |
N/A 2028-06-25 |
BeiGene Ltd. | BGNE | Peterson Amy C. CMO, Immuno-oncology |
310,180 | $12.34 | 310,180 (Direct) |
View |
| 2018-06-26 Gift |
2018-06-28 7:40 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Xiaodong Director |
5,000,000 | $0 | 7,973,444 (Direct) |
View |
| 2018-06-26 Option Award |
2018-06-28 7:40 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Xiaodong Director |
94,133 | $0 | 7,973,444 (Direct) |
View |
| 2018-06-26 Option Award |
2018-06-28 7:40 pm |
N/A 2028-06-25 |
BeiGene Ltd. | BGNE | Wang Xiaodong Director |
655,044 | $12.34 | 7,973,444 (Direct) |
View |
| 2018-06-06 Option Award |
2018-06-08 6:42 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Yi Qingqing Director |
9,290 | $0 | 17,442 (Direct) |
View |
| 2018-06-06 Option Award |
2018-06-08 6:42 pm |
N/A 2028-06-05 |
BeiGene Ltd. | BGNE | Yi Qingqing Director |
17,442 | $16.15 | 17,442 (Direct) |
View |
| 2018-06-06 Gift |
2018-06-08 5:51 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Glazer Donald W. Director |
10,873 | $0 | 4,527,634 (Direct) |
View |
| 2018-06-06 Gift |
2018-06-08 5:51 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Glazer Donald W. Director |
199,992 | $0 | 4,527,634 (Direct) |
View |
| 2018-06-06 Option Award |
2018-06-08 5:51 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Glazer Donald W. Director |
9,290 | $0 | 4,527,634 (Direct) |
View |
| 2018-06-06 Option Award |
2018-06-08 5:51 pm |
N/A 2028-06-05 |
BeiGene Ltd. | BGNE | Glazer Donald W. Director |
17,442 | $16.15 | 4,527,634 (Direct) |
View |
| 2018-06-06 Option Award |
2018-06-08 5:50 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Chen Timothy Yung-Cheng Director |
9,290 | $0 | 17,442 (Direct) |
View |
| 2018-06-06 Option Award |
2018-06-08 5:50 pm |
N/A 2028-06-05 |
BeiGene Ltd. | BGNE | Chen Timothy Yung-Cheng Director |
17,442 | $16.15 | 17,442 (Direct) |
View |
| 2018-06-06 Option Award |
2018-06-08 5:50 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Malley Thomas Director |
9,290 | $0 | 30,000 (Direct) |
View |
| 2018-06-06 Option Award |
2018-06-08 5:50 pm |
N/A 2028-06-05 |
BeiGene Ltd. | BGNE | Malley Thomas Director |
17,442 | $16.15 | 30,000 (Direct) |
View |
| 2018-06-06 Option Award |
2018-06-08 4:05 pm |
N/A N/A |
BeiGene Ltd. | BGNE | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director, 10% Owner |
18,580 | $0 | 73,180,600 (Indirect) |
View |
| 2018-06-06 Option Award |
2018-06-08 4:05 pm |
N/A N/A |
BeiGene Ltd. | BGNE | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director, 10% Owner |
18,580 | $0 | 73,180,600 (Indirect) |
View |
| 2018-06-06 Option Award |
2018-06-08 4:05 pm |
N/A 2028-06-05 |
BeiGene Ltd. | BGNE | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director, 10% Owner |
34,884 | $16.15 | 73,180,600 (Indirect) |
View |
| 2018-04-30 Option Award |
2018-05-02 8:52 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wu Xiaobin President |
1,149,899 | $0 | 1,149,899 (Direct) |
View |
| 2018-04-30 Option Award |
2018-05-02 8:52 pm |
N/A 2028-04-29 |
BeiGene Ltd. | BGNE | Wu Xiaobin President |
766,599 | $13.05 | 1,149,899 (Direct) |
View |
| 2018-04-30 Option Award |
2018-05-02 8:46 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO, 10% Owner |
574,938 | $0 | 29,872,444 (Direct) |
View |
| 2018-04-30 Option Award |
2018-05-02 8:46 pm |
N/A 2028-04-29 |
BeiGene Ltd. | BGNE | OYLER JOHN CEO, 10% Owner |
996,810 | $13.05 | 29,872,444 (Direct) |
View |
| 2018-04-02 Option Award |
2018-04-04 4:47 pm |
N/A 2028-04-01 |
BeiGene Ltd. | BGNE | su Jingshyh S Director |
63,290 | $12.72 | 63,290 (Direct) |
View |
| 2018-03-16 Exercise |
2018-03-20 5:02 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Liang Howard CFO |
10,872 | $6.5 | 4,758,664 (Direct) |
View |
| 2018-03-16 Sale |
2018-03-20 5:02 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Liang Howard CFO |
1,000 | $154.9 | 4,758,664 (Direct) |
View |
| 2018-03-16 Sale |
2018-03-20 5:02 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Liang Howard CFO |
2,208 | $156.7 | 4,758,664 (Direct) |
View |
| 2018-03-16 Sale |
2018-03-20 5:02 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Liang Howard CFO |
7,264 | $157.4 | 4,758,664 (Direct) |
View |
| 2018-03-16 Sale |
2018-03-20 5:02 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Liang Howard CFO |
400 | $158 | 4,758,664 (Direct) |
View |
| 2018-03-16 Exercise |
2018-03-20 5:02 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Liang Howard CFO |
24,128 | $6.5 | 4,758,664 (Direct) |
View |
| 2018-03-16 Sale |
2018-03-20 5:02 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Liang Howard CFO |
500 | $158.4 | 4,758,664 (Direct) |
View |
| 2018-03-16 Sale |
2018-03-20 5:02 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Liang Howard CFO |
5,200 | $159.6 | 4,758,664 (Direct) |
View |
| 2018-03-16 Sale |
2018-03-20 5:02 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Liang Howard CFO |
9,618 | $160.6 | 4,758,664 (Direct) |
View |
| 2018-03-16 Sale |
2018-03-20 5:02 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Liang Howard CFO |
3,141 | $161.6 | 4,758,664 (Direct) |
View |
| 2018-03-16 Sale |
2018-03-20 5:02 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Liang Howard CFO |
5,133 | $162.8 | 4,758,664 (Direct) |
View |
| 2018-03-16 Sale |
2018-03-20 5:02 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Liang Howard CFO |
4,636 | $163.5 | 4,758,664 (Direct) |
View |
| 2018-03-16 Sale |
2018-03-20 5:02 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Liang Howard CFO |
900 | $164.4 | 4,758,664 (Direct) |
View |
| 2018-03-16 Exercise |
2018-03-20 5:02 pm |
N/A 2025-07-01 |
BeiGene Ltd. | BGNE | Liang Howard CFO |
141,336 | $0.5 | 4,758,664 (Direct) |
View |
| 2018-03-16 Exercise |
2018-03-20 5:02 pm |
N/A 2025-07-01 |
BeiGene Ltd. | BGNE | Liang Howard CFO |
313,664 | $0.5 | 4,758,664 (Direct) |
View |
| 2018-02-28 Sale |
2018-03-02 6:42 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO, 10% Owner |
5,117 | $143.5 | 29,890,174 (Direct) |
View |
| 2018-02-28 Sale |
2018-03-02 6:42 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO, 10% Owner |
5,104 | $144.9 | 29,890,174 (Direct) |
View |
| 2018-02-28 Sale |
2018-03-02 6:42 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO, 10% Owner |
4,607 | $146 | 29,890,174 (Direct) |
View |
| 2018-02-28 Sale |
2018-03-02 6:42 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO, 10% Owner |
8,449 | $147 | 29,890,174 (Direct) |
View |
| 2018-02-28 Sale |
2018-03-02 6:42 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO, 10% Owner |
2,302 | $147.8 | 29,890,174 (Direct) |
View |
| 2018-02-28 Sale |
2018-03-02 6:42 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO, 10% Owner |
5,342 | $149.1 | 29,890,174 (Direct) |
View |
| 2018-02-28 Sale |
2018-03-02 6:42 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO, 10% Owner |
3,117 | $149.7 | 29,890,174 (Direct) |
View |
| 2018-02-28 Sale |
2018-03-02 6:42 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO, 10% Owner |
100 | $151 | 29,890,174 (Direct) |
View |
| 2018-02-28 Sale |
2018-03-02 6:42 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO, 10% Owner |
200 | $152 | 29,890,174 (Direct) |
View |
| 2018-02-28 Sale |
2018-03-02 6:42 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO, 10% Owner |
2,600 | $139.1 | 29,890,174 (Direct) |
View |
| 2018-02-28 Sale |
2018-03-02 6:42 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO, 10% Owner |
1,250 | $140.4 | 29,890,174 (Direct) |
View |
| 2018-02-28 Sale |
2018-03-02 6:42 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO, 10% Owner |
3,350 | $141.2 | 29,890,174 (Direct) |
View |
| 2018-02-28 Sale |
2018-03-02 6:42 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO, 10% Owner |
4,787 | $142.2 | 29,890,174 (Direct) |
View |
| 2018-02-28 Sale |
2018-03-02 6:42 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO, 10% Owner |
10,303 | $143.3 | 29,890,174 (Direct) |
View |
| 2018-02-28 Sale |
2018-03-02 6:42 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO, 10% Owner |
14,354 | $144.3 | 29,890,174 (Direct) |
View |
| 2018-02-28 Sale |
2018-03-02 6:42 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO, 10% Owner |
2,656 | $145 | 29,890,174 (Direct) |
View |
| 2018-02-28 Sale |
2018-03-02 6:42 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO, 10% Owner |
1,300 | $141.6 | 29,890,174 (Direct) |
View |
| 2018-02-28 Sale |
2018-03-02 6:42 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO, 10% Owner |
2,600 | $142.7 | 29,890,174 (Direct) |
View |
| 2018-02-28 Sale |
2018-03-02 6:42 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO, 10% Owner |
1,546 | $143.6 | 29,890,174 (Direct) |
View |
| 2018-02-28 Sale |
2018-03-02 6:42 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO, 10% Owner |
600 | $145.3 | 29,890,174 (Direct) |
View |
| 2018-02-28 Sale |
2018-03-02 6:42 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO, 10% Owner |
200 | $146.2 | 29,890,174 (Direct) |
View |
| 2018-02-28 Sale |
2018-03-02 6:42 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO, 10% Owner |
700 | $147.3 | 29,890,174 (Direct) |
View |
| 2018-02-28 Sale |
2018-03-02 6:42 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO, 10% Owner |
2,800 | $148.6 | 29,890,174 (Direct) |
View |
| 2018-02-28 Sale |
2018-03-02 6:42 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO, 10% Owner |
9,032 | $149.7 | 29,890,174 (Direct) |
View |
| 2018-02-28 Sale |
2018-03-02 6:42 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO, 10% Owner |
6,584 | $150.6 | 29,890,174 (Direct) |
View |
| 2018-02-28 Exercise |
2018-03-02 6:41 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Li Ji VP |
10,000 | $26.65 | 2,246,000 (Direct) |
View |
| 2018-02-28 Sale |
2018-03-02 6:41 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Li Ji VP |
1,749 | $143.7 | 2,246,000 (Direct) |
View |
| 2018-02-28 Sale |
2018-03-02 6:41 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Li Ji VP |
1,100 | $144.8 | 2,246,000 (Direct) |
View |
| 2018-02-28 Sale |
2018-03-02 6:41 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Li Ji VP |
1,400 | $146 | 2,246,000 (Direct) |
View |
| 2018-02-28 Sale |
2018-03-02 6:41 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Li Ji VP |
1,800 | $146.9 | 2,246,000 (Direct) |
View |
| 2018-02-28 Sale |
2018-03-02 6:41 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Li Ji VP |
1,551 | $148.7 | 2,246,000 (Direct) |
View |
| 2018-02-28 Sale |
2018-03-02 6:41 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Li Ji VP |
2,400 | $149.5 | 2,246,000 (Direct) |
View |
| 2018-02-28 Exercise |
2018-03-02 6:41 pm |
N/A 2026-05-02 |
BeiGene Ltd. | BGNE | Li Ji VP |
130,000 | $2.05 | 2,246,000 (Direct) |
View |
| 2018-01-18 Purchase |
2018-01-22 5:03 pm |
N/A N/A |
BeiGene Ltd. | BGNE | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director, 10% Owner |
335,050 | $101 | 73,162,024 (Indirect) |
View |
| 2018-01-18 Purchase |
2018-01-22 5:03 pm |
N/A N/A |
BeiGene Ltd. | BGNE | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director, 10% Owner |
1,645,148 | $101 | 73,162,024 (Indirect) |
View |
| 2017-12-26 Sale |
2017-12-28 5:49 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO, 10% Owner |
8,958 | $95.55 | 29,890,174 (Direct) |
View |
| 2017-12-26 Sale |
2017-12-28 5:49 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO, 10% Owner |
8,279 | $96.68 | 29,890,174 (Direct) |
View |
| 2017-12-26 Sale |
2017-12-28 5:49 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO, 10% Owner |
1,700 | $97.83 | 29,890,174 (Direct) |
View |
| 2017-12-26 Sale |
2017-12-28 5:49 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO, 10% Owner |
200 | $99.05 | 29,890,174 (Direct) |
View |
| 2017-12-26 Sale |
2017-12-28 5:49 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO, 10% Owner |
1,000 | $100.1 | 29,890,174 (Direct) |
View |
| 2017-12-21 Exercise |
2017-12-22 4:43 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
1,000 | $29.51 | 1,367,500 (Direct) |
View |
| 2017-12-21 Sale |
2017-12-22 4:43 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
1,000 | $98 | 1,367,500 (Direct) |
View |
| 2017-12-21 Exercise |
2017-12-22 4:43 pm |
N/A 2026-09-02 |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
13,000 | $2.27 | 1,367,500 (Direct) |
View |
| 2017-12-13 Exercise |
2017-12-15 4:05 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
1,500 | $29.51 | 1,380,500 (Direct) |
View |
| 2017-12-13 Sale |
2017-12-15 4:05 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
1,300 | $94.21 | 1,380,500 (Direct) |
View |
| 2017-12-13 Sale |
2017-12-15 4:05 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
200 | $94.53 | 1,380,500 (Direct) |
View |
| 2017-12-13 Exercise |
2017-12-15 4:05 pm |
N/A 2026-09-02 |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
19,500 | $2.27 | 1,380,500 (Direct) |
View |
| 2017-12-06 Sale |
2017-12-08 5:57 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO, 10% Owner |
8,000 | $91.48 | 29,890,174 (Direct) |
View |
| 2017-12-06 Sale |
2017-12-08 5:57 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO, 10% Owner |
18,046 | $92.36 | 29,890,174 (Direct) |
View |
| 2017-12-06 Sale |
2017-12-08 5:57 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO, 10% Owner |
4,000 | $93.02 | 29,890,174 (Direct) |
View |
| 2017-12-06 Sale |
2017-12-08 5:57 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO, 10% Owner |
1,400 | $93.96 | 29,890,174 (Direct) |
View |
| 2017-12-06 Sale |
2017-12-08 5:57 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO, 10% Owner |
24,080 | $92.06 | 29,890,174 (Direct) |
View |
| 2017-12-06 Sale |
2017-12-08 5:57 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO, 10% Owner |
9,439 | $93.23 | 29,890,174 (Direct) |
View |
| 2017-12-06 Sale |
2017-12-08 5:57 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO, 10% Owner |
13,213 | $93.94 | 29,890,174 (Direct) |
View |
| 2017-12-06 Sale |
2017-12-08 5:57 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO, 10% Owner |
7,743 | $94.98 | 29,890,174 (Direct) |
View |
| 2017-12-06 Sale |
2017-12-08 5:57 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO, 10% Owner |
5,162 | $96.12 | 29,890,174 (Direct) |
View |
| 2017-12-06 Sale |
2017-12-08 5:57 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO, 10% Owner |
100 | $96.66 | 29,890,174 (Direct) |
View |
| 2017-12-06 Sale |
2017-12-08 5:57 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO, 10% Owner |
10,809 | $94.91 | 29,890,174 (Direct) |
View |
| 2017-12-06 Sale |
2017-12-08 5:57 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO, 10% Owner |
37,208 | $95.62 | 29,890,174 (Direct) |
View |
| 2017-12-06 Sale |
2017-12-08 5:57 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO, 10% Owner |
4,800 | $96.67 | 29,890,174 (Direct) |
View |
| 2017-12-04 Sale |
2017-12-05 09:15 am |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
1,100 | $86 | 264,900 (Indirect) |
View |
| 2017-11-27 Sale |
2017-11-29 5:33 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO, 10% Owner |
16,346 | $86.75 | 29,890,174 (Direct) |
View |
| 2017-11-27 Sale |
2017-11-29 5:33 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO, 10% Owner |
235 | $87.49 | 29,890,174 (Direct) |
View |
| 2017-11-27 Sale |
2017-11-29 5:33 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO, 10% Owner |
32,985 | $85.52 | 29,890,174 (Direct) |
View |
| 2017-11-27 Sale |
2017-11-29 5:33 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO, 10% Owner |
36,340 | $82.92 | 29,890,174 (Direct) |
View |
| 2017-11-16 Sale |
2017-11-20 5:14 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
600 | $85 | 264,900 (Indirect) |
View |
| 2017-11-16 Sale |
2017-11-20 5:14 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
1,000 | $87 | 264,900 (Indirect) |
View |
|
© 2005-2019 SecForm4.Com All rights reserved. Archives: 2019 2018 2017 2016 2015 2014 ... Thu, 17 Jan 2019 11:19:07 -0600 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |